Wagner-Drouet, E., Teschner, D., Wolschke, C., Janson, D., Schäfer-Eckart, K., Gärtner, J., . . . Wolff, D. (2021). Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation. Haematologica, 106(2), . https://doi.org/10.3324/haematol.2019.229252
Chicago-Zitierstil (17. Ausg.)Wagner-Drouet, Eva, et al. "Standardized Monitoring of Cytomegalovirus-specific Immunity Can Improve Risk Stratification of Recurrent Cytomegalovirus Reactivation After Hematopoietic Stem Cell Transplantation." Haematologica 106, no. 2 (2021). https://doi.org/10.3324/haematol.2019.229252.
MLA-Zitierstil (9. Ausg.)Wagner-Drouet, Eva, et al. "Standardized Monitoring of Cytomegalovirus-specific Immunity Can Improve Risk Stratification of Recurrent Cytomegalovirus Reactivation After Hematopoietic Stem Cell Transplantation." Haematologica, vol. 106, no. 2, 2021, https://doi.org/10.3324/haematol.2019.229252.